Company Filing History:
Years Active: 1984-1988
Title: Fred Letterio: Innovator in Medical Technology
Introduction
Fred Letterio is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of medical technology, particularly in non-invasive methods for measuring blood glucose concentration. With a total of 3 patents to his name, Letterio's work has the potential to impact the lives of many individuals managing diabetes.
Latest Patents
One of his latest patents is a method and apparatus for measuring blood glucose concentration. This innovative approach provides a non-invasive way to measure glucose levels using the glucose present at the mucosal surface of a living being. The method involves positioning a glucose oxidase membrane on the mucosal surface, supplying oxygen for peroxidative oxidation of the glucose, and electrically measuring the amount of hydrogen peroxide produced. This measurement is then calibrated to determine the blood glucose concentration. Additionally, the patent includes electrode devices suitable for carrying out this method.
Career Highlights
Throughout his career, Fred Letterio has worked with various companies, including Xienta, Inc. His experience in the medical technology sector has allowed him to develop groundbreaking solutions that address critical health issues.
Collaborations
Fred has collaborated with notable individuals in his field, including Richard Reinhart and Peter Pugliese. These partnerships have contributed to the advancement of his innovative projects and patents.
Conclusion
Fred Letterio's contributions to medical technology, particularly in non-invasive glucose measurement, highlight his role as an influential inventor. His work continues to pave the way for advancements in healthcare solutions.